Colgate-Palmolive (CL) stock has seen some pressure recently, slipping over the past month. Investors have been following its performance closely in light of the company’s steady role in the household products sector and its long-term track record.
See our latest analysis for Colgate-Palmolive.
After a modest pullback in the past month, Colgate-Palmolive’s share price has largely trended sideways this year, which suggests that momentum has cooled. Despite this, total shareholder return over the past three years remains positive, reflecting the company’s enduring stability even as markets shift.
If you’re interested in broadening your scope, now is a great moment to discover fast growing stocks with high insider ownership.
With shares still trading below analyst price targets and Colgate-Palmolive offering solid fundamentals, investors are left wondering if today’s price is a rare entry point or if the market is fully accounting for future growth.
Most Popular Narrative: 15.9% Undervalued
Colgate-Palmolive’s last close of $78.31 is well below the most widely followed fair value estimate of $93.11, setting up a bullish opportunity if future growth matches forecasts. The narrative centers on strategic expansion in both emerging markets and digital channels, with profitability expected to improve and value potentially unlocked over the next three years.
Expansion and premiumization of core oral care lines like Colgate Total, together with the introduction of complementary products across 75 markets, aim to capture increased value from emerging middle-class consumers and rising health and hygiene awareness globally. This could support top-line organic sales growth and improved pricing power.
Curious about what projections place Colgate-Palmolive’s value so far above today’s share price? The narrative is built on ambitious forecasts for revenue momentum and a profit multiple that aligns with industry leaders. Only by reading further will you discover which assumptions and numbers could justify this target.
Result: Fair Value of $93.11 (UNDERVALUED)
Have a read of the narrative in full and understand what's behind the forecasts.
However, persistent cost pressures and cautious consumer spending in key markets could still curb revenue momentum and challenge the most optimistic growth assumptions.
Find out about the key risks to this Colgate-Palmolive narrative.
Build Your Own Colgate-Palmolive Narrative
If the current outlook does not fit your perspective, or you would rather analyze the numbers firsthand, you can build your own thesis in just a few minutes. Do it your way.
A great starting point for your Colgate-Palmolive research is our analysis highlighting 4 key rewards and 1 important warning sign that could impact your investment decision.
Looking for More Investment Ideas?
Step ahead of the crowd by using these handpicked opportunities to expand your portfolio. Don’t let today’s market winners pass you by. Taking action can create an advantage.
- Jump on high-potential tech trends by identifying the next market movers with these 24 AI penny stocks.
- Secure consistent income streams by connecting with these 19 dividend stocks with yields > 3% offering yields above 3% right now.
- Strengthen your portfolio against volatility by tapping into these 31 healthcare AI stocks transforming the future of medicine.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Valuation is complex, but we're here to simplify it.
Discover if Colgate-Palmolive might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com